Pathological response of gastrointestinal stromal tumour to imatinib treatment correlates with tumour KIT mutational status in individual tumour clones

This publication has 7 references indexed in Scilit:

• Pathological changes related to Imatinib treatment in a patient with a metastatic gastrointestinal stromal tumour
  Histopathology, 2005
• Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants
  Gastroenterology, 2005
• Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group
  European Journal Of Cancer, 2004
• Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
  Journal of Clinical Oncology, 2003
• Images in Pathology
  International Journal of Surgical Pathology, 2003
• Complete remission of a metastatic gastrointestinal stromal tumour with the tyrosine kinase inhibitor imatinib (STI 571)
  European Journal of Gastroenterology & Hepatology, 2003
• Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor
  New England Journal of Medicine, 2001